Understanding Deramaxx

Understanding Deramaxx®

Smart Drug or Clever Marketing?

Silk, my 9 year old Dobie, injured her left rear leg and was prescribed Deramaxx® which she took for just two days. Needless to say, three days and $1,500.00 dollars later, the specialists are still giving her IV fluids. A scope was performed today by an internal medicine specialist who found that the entire stomach lining had been sloughed off. Her symptoms were violent vomiting which included blood, bloody stool and bleeding from the rectum. IV fluids will be maintained for at least two more days, which will make that a total of 5 days on IV fluids.
Cheryl Hartman
As of March 14th, Cheryl's bill for treating Silk is now $3,470.53.

Deramaxx® is a non-steroidal anti-inflammatory (NSAID) marketed by Novartis Animal Health Products. The essence of the Novartis marketing campaign is that because Deramaxx® is a Cox-2 specific NSAID it is both safer and more effective than other veterinary NSAIDs. Claims like this have been disallowed by the Food and Drug Administration for human Cox-2 inhibitors. Cox-2 inihibitors simply trade one set of side effects for another.

As with any NSAID, it is a medicine to be taken wisely since the side effects can include death.

As of February 24, 2003, the Center for Veterinary Medicine of the Food and Drug Administration had received reports of the death of 27 dogs which were possibly linked to Deramaxx®. Reported adverse events typically represent about 10%-15% of actual events.

This website has been created to provide information on using Deramaxx® intelligently and dealing with problems should they arise.


Deramaxx® Information


The information presented on this site is intended to assist pet owners in making intelligent decisions regarding the use of Deramaxx®. It is not veterinary advice. Owners need to work closely with their veterinarians in deciding whether to use Deramaxx® and in treating their companions if they experience an adverse reaction.


Home | Comments, Questions, Suggestions

© Copyright 2003. Edward Murray. All rights reserved.
Material on this site may be freely copied provided a link is provided to the site.